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Abstract
A case of POF in a 31-year-old woman with karyotype 47,XXX. The aim of the study was to discuss a case of POF in a 31-year-old patient
with polysomy 47,XXX. The described karyotype is not usually associated with this characteristic physical phenotype. In some rare cases,
menstrual disorders, sterility, secondary amenorrhoea, premature menopause, and low intelligence are found.
Our observations revealed the necessity for cytogenetic examination in all women at reproductive age with symptoms of premature
ovarian failure. According to the data found in literature, patients with POF and karyotype disorders belong to the risk group of premature
death, mostly for cardiological reasons. Raising patient awareness about the risk may have a positive effect on quality of life and regularity
of check-ups.
(Pol J Endocrinol 2010; 61 (2): 217–219)
Key word: premature ovanian failure, polisomy 47,XXX, secondary amenorrhoea
Streszczenie
Przypadek POF u 31-letniej kobiety z kariotypem 47, XXX (zespół przedwczesnego wygasania czynności jajników [POF, premature ovarian
failure]). Celem pracy była analiza przypadku 31-letniej kobiety diagnozowanej z powodu POF, u której stwierdzono polisomię 47,XXX.
Opisywany kariotyp zwykle nie jest związany z charakterystycznymi cechami fenotypowymi. Tylko w niektórych przypadkach stwier-
dza się: zaburzenia miesiączkowania, niepłodność, wtórny brak miesiączki, zespół przedwczesnego wygasania czynności jajników i defi-
cyty intelektualne.
Obserwacja autorów pracy wykazała konieczność badania cytogenetycznego u wszystkich kobiet w wieku rozrodczym z objawami POF.
Dostępne dane z piśmiennictwa identyfikują pacjentki z POF i nieprawidłowościami kariotypu jako grupę zagrożoną przedwczesnymi
zgonami — głównie z przyczyn kardiologicznych. Uświadomienie ryzyka tym pacjentkom może wpłynąć na korzystne zmiany stylu
życia i regularność badań. (Endokrynol Pol 2010; 61 (2): 217–219)
Słowa kluczowe: przedwczesne wygasanie czynności jajników, polisomia 47,XXX, wtórny brak miesiączki
One of the causes of premature ovarian failure (POF) is
related to chromosomal abnormalities. Portnoi et al. [1]
performed cytogenetic examinations in 90 patients with
diagnosed POF and found an abnormal karyotype in
8.8% of cases. The group also included one case of
47,XXX. Other literature data confirm that the 47,XXX
karyotype may be associated with POF revealing itself
in during puberty as well as the reproductive period.
According to Goswami [2], 3.8% of women with POF
have the 47,XXX karyotype. In women with POF and
the 47,XXX karyotype, autoimmunological disorders of
thyroid and/or adrenal glands may occur.
It is estimated that 1 woman in 1000 has an addi-
tional X chromosome, and that those women do not
display characteristic symptoms, suggesting the de-
scribed disorder. [3] Therefore, they do not demonstrate
the typical phenotype of the 47,XXX women. Women
with X polysomy may display: underdevelopment of
secondary sex characters, retarded sexual maturation,
and primary or secondary amenorrhoea caused by pre-
mature ovarian failure. Congenital defects may also
occur, including: obliteration of the duodenum, con-
genital hyperplasia of adrenal glands (11b-hydroxylase
deficit), cheilognathopalatoschisis, a contracture of the
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distal phalanx of the fifth finger, epicanthal fold, and
transverse flexion creases of the palm. In some cases,
mental impairment is found. It must be emphasized that
a large group of the patients do not display any pheno-
typical abnormalities or traits of mental impairment. [4]
Case report
The patient, AH, aged 31, was admitted to the clinic due
to a secondary amenorrhoea, hot flushes, and second-
ary infertility. The patient had secondary education and
was employed as a clerical worker. AH spontaneously
miscarried a 10-week pregnancy two years previously.
The miscarriage was an arrested abortion. In 2007 the
patient had a uterine myoma enucleated surgically in
the course of a laparotomy. The patient had two elder,
healthy sisters. Her parents were under 30 years old at
the time of her birth. She menstruated for the first time
at the age of 12. Then she menstruated irregularly at
intervals of 60–180 days. The menstruations were abun-
dant, with clots and accompanying pain complaints.
As a girl, she developed normally. At the moment
of admission to the clinic, at the age of 31, she was
167 cm tall, weighed 52 kg, and her BMI was 18.65. She
had an asthenic female body build. A gynaecological
examination revealed normal vulva and perineum, and
female pubic and axillary hair. Ectopy was found on
the vaginal part of the uterine cervix. The body of the
uterus was slightly enlarged, in retroflexion, with poor
mobility. The adnexa on both sides were impalpable and
painless in examination.
The results of hormone level determination were
as follows: FSH: 127.90 mIU/MI, LH: 11.87 UI/L, E2:
67.77 pmol/L, free testosterone: 0.99 pg/ml, total testo-
sterone: 0.28 nmol/L, 17-OH: 0.50 ng/mL, androstendione:
2.08 ng/ml, TSH: 1.032 uIU/mL, fT3: 2.92 pg/ml, fT4:
1.09 ng/dL. Daily profiles of prolactin and cortisol were
normal. No antithyroid or antiadrenal antibodies were
found in the blood. The COMBI test (AMA, APCA, ASMA,
LKM) and the anticardiolipin tests were negative.
An ultrasonographic examination of the pelvis mi-
nor, performed with an intravaginal probe, showed: the
body of the uterus in retroflexion, with size 41 × 52 mm,
of a slightly non-homogeneous echo pattern; en-
dometrium — 6 mm thick, homogeneous; right ovary
of size 29 × 21 mm, 6 ml volume, with two echo-nega-
tive areas of 10 and 8 mm in diameter; and left ovary of
size 18 × 15 mm, 2 ml volume. A cytogenetic examina-
tion, performed by GTG technique with the degree of
band resolution according to ISCN: 400–500, after an
analysis of 58 metaphase plates, an X chromosome tri-
somy was diagnosed: 47,XXX. The examination was
performed at the Cytogenetic Laboratory of the Depart-
ment of Medical Diagnostics at the Silesian Centre of
Child’s and Mother’s Health of the Medical University
in Katowice. A psychologist’s consultation revealed the
patient’s normal psychological condition.
Discussion
X chromosome trisomy is a result of sex chromosomes
not being disjuncted in the first meiotic division. The
defect is closely related to the mother’s age: the older
the mother, the higher the risk of XXX trisomy occur-
ring in the daughter. According to Deng et al. [5], in
cases of X polysomy, the additional X chromosome
comes from the mother.
The first case of a woman with X trisomy was de-
scribed by Jacobs in 1959 [6]. Apart from a secondary
amenorrhoea, she did not display any other psychic,
physical, or sexual disorders.
The standard diagnostic procedure in the case of
young women with primary or secondary amenorrhoea
should include a cytogenetic examination. The princi-
ple is understood and accepted by most gynaecologists
in the case of women under the age of 25; in older pa-
tients the examination is usually not performed, as the
described case demonstrates.
As has been emphasized in the introduction, there
is no typical phenotype for women with 47,XXX. In
women with 47,XXX polysomy and POF, immunologi-
cal disorders may occur. In 2003 Masanori et al. [7] de-
scribed a patient with 47,XXX polysomy and a coexist-
ing pure red cell aplasia (PRCA), manifesting itself with
anaemia and panmyelophthisis. Michalak et al. [8] de-
scribed a 47,XXX patient with premature ovarian fail-
ure and autoimmunological disorders. Goswami [2]
examined 52 patients with POF and found that in 2 of
them, besides X trisomy, an autoimmunological thyroid
disease occurred. Lanoble et al. [9] presented a 47,XXX
patient with systemic visceral lupus. Even though our
patient did not display immunological disorders or dis-
orders of the thyroid and adrenal glands, the addition-
al X chromosome may still play an important role in
the functioning of the immunological system, and spe-
cial medical care should be given the patient.
Harmon et al. [10] suggest that the additional X chro-
mosome in a woman may determine her tall stature.
This is not confirmed by our case, in which the patient
had a normal stature of 167 cm, or by another case de-
scribed previously in our centre, in which the patient
was of short stature.
Some women with X polysomy become pregnant.
There have been descriptions of children with Down
syndrome being born from mothers with the 48,XXXX
karyotype [5]. Kesaree and Wolley [11] described the
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case of a woman with the 49,XXXXX karyotype with
retarded physical and mental development. Goswami
[2] described a woman with POF and 47,XXX karyo-
type, who became pregnant twice. The first pregnancy
ended in a premature birth and idiopathic thrombocy-
topenia being diagnosed in the child. From the second
pregnancy a child with cerebral hernia was born and
died soon thereafter.
According to Barr et al. [12], who presented 12 of
their own cases of X triploidy as well as an extensive
review of literature, the 47,XXX trisomy does not cause
structural and functional changes of the reproductive
system. Among the 101 women described, 73 menstru-
ated regularly or irregularly, had normally developed
breasts, and did not display any significant disorders of
the reproductive system. Twenty-eight women bore
children, among whom boys prevailed. In 29 children,
cytogenetic examination was conducted, with normal
results in 24 cases. The review of literature quoted by
the author may, however, include cases of women with
46,XX/47,XXX mosaicism as well.
In our centre, 2 cases of pure 47,XXX trisomy were
observed in the period from 1999 to 2009. The first wom-
an was infertile, while the patient described in the
present work had one arrested miscarriage.
The study conducted by Swerdlow et al. [3] on
a group of 542 X polysomy patients demonstrated that
the risk of incidence and mortality due to a neoplastic
disease was not higher than in the general population,
while the mortality rate due to a non-Hodgkin lympho-
ma was significantly higher. A higher number of car-
dio-vascular deaths was also found.
It should be assumed that 47,XXX trisomy increases
the risk of ovarian dysfunction or pathology.
As was stressed in the introduction, some patients
with 47,XXX polysomy do not display mental retarda-
tion or phenotypical disorders, have normal reproduc-
tive functions, and their offspring are characterized by
normal chromosome complement. Patients with X tri-
somy live shorter lives; therefore a correct diagnosis may
facilitate taking decisions regarding the prevention and
treatment of diseases accompanying this disorder.
The standard diagnostic procedure should include
a cytogenetic examination. The principle is understood
and accepted by most gynaecologists and endocrinolo-
gists in the case of women under the age of 25; in older
patients the examination is frequently neglected. The
described case of a 31-year-old patient with POF and
the 47,XXX karyotype confirms the above observation.
We recommend, therefore, that a cytogenetic examina-
tion should be performed in patients with primary ova-
rian failure.
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